Literature DB >> 2239825

Measuring platelet aggregation with microplate reader. A new technical approach to platelet aggregation studies.

J C Fratantoni1, B J Poindexter.   

Abstract

Platelet aggregation measurements were done with the use of a commercially available microtiter plate reader with specific modification of the mode of agitation of the samples. Satisfactory aggregation curves were obtained with use of an external horizontal agitator, with an amplitude of 1.3 mm and minimum frequency of 1,360 cycles/minute. With the use of the 96 available wells in the microtiter plates, all test and control platelet samples, with replicates, were observed simultaneously and the output data obtained within 10-15 minutes. The technique was validated by demonstrating the similarity of dose-response curves, obtained with a standard aggregometer and with the microtiter technique, of platelets stimulated by adenosine diphosphate, thrombin, and arachidonic acid.

Entities:  

Mesh:

Year:  1990        PMID: 2239825     DOI: 10.1093/ajcp/94.5.613

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  13 in total

1.  Effects of vitamin E on human platelet and mononuclear cell responses in vitro.

Authors:  J C Williams; L A Forster; S P Tull; G A Ferns
Journal:  Int J Exp Pathol       Date:  1999-08       Impact factor: 1.925

2.  Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity.

Authors:  S Konstantinides; K Schäfer; S Koschnick; D J Loskutoff
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

3.  Amphotericin B induced abnormalities in human platelets.

Authors:  K B Pastakia; N E Brownson; D A Terle; B J Poindexter
Journal:  Clin Mol Pathol       Date:  1996-10

4.  Agonist and antagonist effects of diadenosine tetraphosphate, a platelet dense granule constituent, on platelet P2Y1, P2Y12 and P2X1 receptors.

Authors:  Hung Chang; Ivan B Yanachkov; Alan D Michelson; YouFu Li; M R Barnard; George E Wright; Andrew L Frelinger
Journal:  Thromb Res       Date:  2009-11-27       Impact factor: 3.944

5.  The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active.

Authors:  Corinne Barat; Geneviève Martin; Adrien R Beaudoin; Jean Sévigny; Michel J Tremblay
Journal:  J Mol Biol       Date:  2007-05-10       Impact factor: 5.469

6.  Application of high-throughput screening to identify a novel alphaIIb-specific small- molecule inhibitor of alphaIIbbeta3-mediated platelet interaction with fibrinogen.

Authors:  Robert Blue; Marta Murcia; Charles Karan; Markéta Jirousková; Barry S Coller
Journal:  Blood       Date:  2007-10-31       Impact factor: 22.113

7.  Staphylococcal enterotoxin B initiates protein kinase C translocation and eicosanoid metabolism while inhibiting thrombin-induced aggregation in human platelets.

Authors:  Uyen Tran; Thomas Boyle; Jeffrey W Shupp; Rasha Hammamieh; Marti Jett
Journal:  Mol Cell Biochem       Date:  2006-03-21       Impact factor: 3.396

8.  Development of a microplate coagulation assay for Factor V in human plasma.

Authors:  Derek Tilley; Irina Levit; John A Samis
Journal:  Thromb J       Date:  2011-06-28

9.  Measurement of factor v activity in human plasma using a microplate coagulation assay.

Authors:  Derek Tilley; Irina Levit; John A Samis
Journal:  J Vis Exp       Date:  2012-09-09       Impact factor: 1.355

10.  Antiplatelet activity, P2Y₁ and P2Y₁₂ inhibition, and metabolism in plasma of stereoisomers of diadenosine 5',5'″-P¹ ,P⁴-dithio-P²,P³-chloromethylenetetraphosphate.

Authors:  Hung Chang; Ivan B Yanachkov; Edward J Dix; Milka Yanachkova; Youfu Li; Marc R Barnard; George E Wright; Alan D Michelson; Andrew L Frelinger
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.